Skip to main content

Day: March 26, 2020

iBio Announces Advancement of COVID-19 Vaccine Program

NEW YORK, March 26, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biologics contract manufacturing organization and biotechnology company, today announced that immunization studies for its SARS-CoV-2 Virus-Like Particle (“VLP”) program (“IBIO-200”) are proceeding at Texas A&M University System (“TAMUS”) laboratories. The work is being performed as part of the Master Joint Development Agreement established between iBio and TAMUS in 2016.  “This next stage of work on IBIO-200 is critically important as we seek to quickly enter the clinic with one of our VLP candidates,” said Tom Isett, Co-Chairman & Chief Executive Officer of iBio. “As we optimize our choice of adjuvants with both VLP types we have developed, we are fortunate to have a strong relationship with TAMUS that allows us to...

Continue reading

Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates

CAMBRIDGE, Mass., March 26, 2020 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative cell therapies for solid tumors, today announced financial results for the fourth quarter and full year ended December 31, 2019, and provided corporate updates.“We recently announced the conclusion of our Phase 1 ACTR707 programs and restructuring to prioritize our capabilities and resources towards advancing our preclinical program, BOXR1030, and BOXR platform aimed at discovering novel ‘bolt-on’ transgenes to help T cells survive longer and perform better in the solid tumor microenvironment,” said Chuck Wilson Ph.D., President and Chief Executive Officer of Unum. “While taking steps internally to advance BOXR1030 and the BOXR platform given the broad potential we see to improve cell...

Continue reading

Alderon Provides Corporate Update

VANCOUVER, British Columbia, March 26, 2020 (GLOBE NEWSWIRE) — Alderon Iron Ore Corp. (TSX: IRON) (“Alderon” or the “Company”) announces an update with respect to transaction and corporate matters. Alderon previously announced a letter of intent (the “LOI”) with the Tunghsu Group Co., Ltd. (“Investor”) with respect to an investment transaction (the “Transaction”) (see press release dated February 18, 2020). Since the announcement of the Transaction, Alderon and Tunghsu have been negotiating the terms of the definitive agreements for the Transaction and have made substantial progress. Unfortunately, during this period, the outbreak of the novel coronavirus (COVID-19) has developed into a pandemic and this is having a material adverse effect on global economic conditions. Citing the volatility and uncertainty created by...

Continue reading

Aleafia Health Launches Last-Mile Medical Cannabis Home Delivery Service

Service will provide next day direct-to-home delivery to medical cannabis patientsInitial launch in Greater Golden Horseshoe Region, centred around Toronto, with a population of over 9 millionMitigates risk of using postal service and third-party parcel delivery which may be disrupted during COVID-19 pandemicTORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) is launching its last-mile medical cannabis home delivery service. It will provide patients next-day, direct-to-home delivery on medical cannabis orders made in Ontario’s Greater Golden Horseshoe Region (“GGHR”), home to over 9 million people.By delivering directly to patients’ homes, the service provides safe, contactless delivery, eliminating the need for customers to pick-up products at post offices and...

Continue reading

Additional information (meeting location was changed and alternative draft resolution was submitted) on the Ordinary General Meeting of Shareholders of Žemaitijos pienas, AB

16 March 2020 Žemaitijos pienas, AB announced that at the initiative and by the decision of the Board, the Ordinary General Meeting of Shareholders shall be convened on 9 April 2020, at 3 p.m. The meeting shall begin at 3:00 p.m. (shareholder registration shall be conducted from 2:00 p.m. to 2:40 p.m.).We would like to call attention of all shareholders to the fact that the meeting location has been changed from Sedos St. 34a, Telšiai (one of the conference rooms of Telšiai County Business Incubator) to Sedos St. 35, Telšiai.Meeting location — Sedos St. 35, Telšiai (one of the meeting halls of the Company).We would also like to point out that the alternative draft resolution has been received as well as the updated (includes alternative draft resolution) general (advance voting) bulletin. Both documents are attached to this notification...

Continue reading

Papildoma informacija (pakeista susirinkimo vieta ir pateiktas alternatyvus sprendimo projektas) dėl AB “Žemaitijos pienas” eilinio visuotinio akcininkų susirinkimo

2020 m. kovo 16 d. AB „Žemaitijos pienas“ pranešė, jog  valdybos iniciatyva ir  jos sprendimu, 2020 m. balandžio 9 d., 15.00 val. šaukiamas eilinis visuotinis akcininkų susirinkimas. Susirinkimo pradžia – 15:00 val. (akcininkų registracijos pradžia nuo 14:00 val. iki 14 val. 40 min.)1.Atkreipiame visų akcininkų dėmesį, jog susirinkimo vieta pakeista iš vietos nurodytos adresu Sedos g. 34a, Telšiai (Telšių apskrities verslo inkubatorius, viena iš konferencijų salių) į vietą – Sedos g. 35, Telšiai.Susirinkimo vieta – Sedos g.35, Telšiai (viena iš Bendrovės posėdžių salių).Taip pat pažymime, kad yra gautas alternatyvus sprendimo projektas, kuris pateikiamas kartu su šiuo pranešimu, taip pat pridedamas ir atnaujintas (įtrauktas alternatyvus sprendimo projektas) bendrasis (išankstinio balsavimo) biuletenis.Pridedamas (žr. žemiau) papildytas...

Continue reading

NPinvestor.com A/S: Referat af ordinær generalforsamling i NPinvestor.com A/S

Selskabsmeddelelse 42/202026. marts 2020Referat af ordinær generalforsamling i NPinvestor.com A/SDen 26. marts 2020 blev der afholdt ordinær generalforsamling i NPinvestor.com A/S, CVR-nr. 26 51 81 99, (”Selskabet”), hos KLAR Advokater, Indiakaj 12, 2100 København Ø.Alle bestyrelsens forslag blev vedtaget.Referat af ordinær generalforsamling i NPinvestor.com A/S er vedlagt på følgende link: https://npinvestor.com/sites/npinvestor.com/files/download/Generalforsamlingsprotokollat-26032020.pdf Om NPinvestor.com A/SNPinvestor.com A/S (NPinvestor gruppen) er en dansk fintech virksomhed indenfor trading- og investeringsmarkedet. Vi tilbyder nye og bedre muligheder for, at private og professionelle investorer kan handle, investere og pleje deres formue.NPinvestor.com A/S er noteret på Nasdaq First North Growth Market Denmark. Ticker kode: NPINVNPinvestor...

Continue reading

Centerra Gold Announces Dividend of C$0.04 per share

TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra”) (TSX: CG) announced today that its Board of Directors has authorized a dividend of C$0.04 per common share or C$11,751,182 (approximately US$8.2 million at the current exchange rate).  The dividend of C$0.04 per common share is payable on April 22, 2020 to shareholders of record on April 8, 2020.  The ex-dividend date will be April 6, 2020.  The dividend is an eligible dividend for Canadian income tax purposes.Centerra continues to monitor closely and proactively the evolving situation relating to COVID-19 and how it may affect the Company’s business.  The Company notes that going forward, in addition to the other factors that the Board of Directors normally considers in connection with the declaration of dividends, it will also need to carefully consider...

Continue reading

Centerra Gold Records Net Loss for 2019 of $94 million or $0.32 per Common Share Adjusted Net Earnings (Non-GAAP) of $182 million or $0.62 per Common Share; Declares Dividend of CAD$0.04 per Common Share; Provides COVID-19 Update

All figures are in United States dollars and all production figures are on a 100% basis unless otherwise stated.TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) today reported fourth quarter and full-year 2019 results. Key events and operating results of the fourth quarter and year included:Net loss for the quarter of $12.2 million, $0.04 per common share (basic) and net loss for the year of $93.5 million, $0.32 per common share (basic).Adjusted net earningsNG for the quarter of $22.3 million, $0.08 per common share (basic) and adjusted net earningsNG for the year of $181.5 million, $0.62 per common share (basic).Cash flow from operations for the quarter and year was $92.5 million and $334.1 million, respectively. Adjusted cash flow from operationsNG for the quarter and year was...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.